Table 2 Baseline clinical characteristics of the AIS patients and normal controls
From: Increased serum exosomal miR-134 expression in the acute ischemic stroke patients
Parameter | AIS patients (n = 50) | Control (n = 50) | P value |
|---|---|---|---|
Mean age | 65.42 ± 10.25 | 63.33 ± 14.32 | > 0.05 |
Gender (Male/Female) | 26/24 | 22/28 | > 0.05 |
Race (Asian, %) | 100% | 100% | > 0.05 |
Ethnicity (Han, %) | 100% | 100% | > 0.05 |
Stroke risk factors | |||
 Hypertension | 30 (60.0%) | 27 (54.0%) | > 0.05 |
 Diabetes mellitus | 24 (48.0%) | 8 (16.0%) | < 0.01 |
 Atrial Fibrillation | 15 (30.0%) | 12 (24.0%) | > 0.05 |
 Hyperlipidemia | 30 (60.0%) | 13 (26.0%) | < 0.01 |
 NIHSS score | 7.82 ± 1.36 | NA | NA |
 mRS ≤2 | 32 (64.0%) | NA | NA |
   > 2 | 18 (36.0%) | NA | NA |